Is Bliss GVS Pharma Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Bliss GVS Pharma Limited pays dividends. Last time was Saturday 24th of August 2024 where the investors holding the stock on Thursday 18th of July 2024 were paid INR0.5 per share. Over the last 20 times between 2010 and 2024, Bliss GVS Pharma Limited has paid INR9.85 with an average of INR0.49 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Bliss GVS Pharma Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR108.05, you would have made a profit of INR20.60 per share or 19.07%
Yes, the average daily trading liquidity for Bliss GVS Pharma Limited is INR817 245 thousand. You should therefore be able to get in and out of your positions relatively fast.
Bliss GVS Pharma Limited has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.32, the company's ability to pay off the debt is normal. Bliss GVS Pharma Limited has a good net profit margin of 9.80% and should have high tolerances against inflation.
We have calculated the inflation risk for Bliss GVS Pharma Limited to be low [0.25 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.